Erythrose reductases (ERs) convert D-erythrose into meso-erythritol using NADPH as the reductant in an erythritol producing fungi. We characterized three isozymes of erythrose reductases (ER-I, ER-II, and ER-III) biochemically from Trichosporonoides megachiliensis SNG-42, one of the strains used for commercial production of erythritol. 1, 2) In Candida magnoliae, partial amino acid sequences of the enzyme, which had erythrose reductase activity, have been reported, 3) but the entire primary structures and the corresponding cDNAs for ERs remain unknown. In this paper, we report the primary structure, cDNA isolation, and functional expression of erythrose reductases in Escherichia coli. Successful expression of the functional ERs should open a window to produce erythritol in other microorganisms, which do not produce erythritol. This is the first report on the primary structure, molecular cloning and functional expression of the erythrose reductases.
Materials and Methods
Purification of erythrose reductases and peptide mapping of ER-I and ER-III. Trichosporonoides megachiliensis SN-G42 cells, a mutant strain from T. megachiliensis SN-124A (previous name: Aureobasidium megachiliences), were cultured in a medium containing 40% (w/v) glucose (Nacalai Tesque, Tokyo). Purification of ER-I and ER-III was achieved as described previously. 1, 2) Before proteolytic digestion, the cysteinyl residues were reduced and alkylated. ER-I (1 nmole) and ER-III (3 nmole) were dissolved in 200 ml of deoxygenated 10 mM Tris-HCl/6 M urea (pH 8.0). Complete reduction was carried out in the presence of 10 mM dithiothreitol at 45 C for 2 h. Then 15 ml of 1 M 4-vinylpyridine was added and incubation was continued at room temperature for 30 min. This alkylation reaction was terminated by adding 15 ml of 1 M cysteine hydrochloride. The reaction mixture was diluted with water up to 300 ml and subjected to the subsequent proteolytic digestion without further purification. Lysyl endopeptidase (Wako Pure Chemicals, Osaka): 1:100 molar ratio to substrates, 37 C 20 h; chymotrypsin (Sigma, St. Louis, MO): 1:100 molar ratio, 25 C 24 h; Staphylococcus aureus Glu-C endopeptidase (Roche, Tokyo): 1:20 (w/w), 37 C 20 h. ER-III (3 nmole) was dissolved in 200 ml deoxygenated 50 mM Hepes-KOH (pH 8.0) containing 0.1% SDS. ER-III was denatured at 95 C for 5 min and their primary amino groups were alkylated with 10 mM C for 16 h. The citraconyl groups on ER-III were removed by acidification with 0.1% trifluoroacetic acid (TFA) before HPLC separation. The peptide fragments produced in proteolytic digestion were separated on an ODS 80Tm column (4:6 Â 200 mm; Toso, Tokyo) with a linear gradient of 5-80% acetonitrile in 0.05% TFA (90 min). Amino-acid sequencing was done on an ABI 473A gas-phase peptide sequencer (Applied Biosystems, Foster City, CA). All reagents were glacial grade chemicals from Nacalai Tesque unless otherwise noted.
Reverse transcription-polymerase chain reaction (RT-PCR) and Northern blot analysis. Poly A þ -RNA was purified from cells at 72 h culturing time with Trizol reagent (Invitrogen, Carlsbad, CA) and a Dynabeads mRNA purification kit (Nihon Dynal, Tokyo) as directed by the manufacturer. Reverse transcription was performed with 1 mg mRNA, 0.5 mg oligo (dT) 12À15 primer (Amersham Biosciences) and SuperScript IIÔ reverse transcriptase (Invitrogen) at 42 C for 90 min. After reverse transcription (RT), the remaining RNA was then digested with RNAse H (Invitrogen). PCR primers (sense, CAR/GAR/CTN/TTY/GAY/CAY/GG; antisense, TGN/GCY/TCN/ATY/TGR/TTN/AC) were designed from the peptide fragments (QELFDQG and VNQIEAH). Using the first strand cDNA from the RT reaction as a template, a PCR reaction was carried out at 30 thermal cycles of 94 C 1 min, 40 C 1 min, and 68 C 1 min with the primers and Pfu DNA polymerase (Stratagene, La Jolla, CA). An amplified 389 bp fragment was ligated to pBlueScript SK+ (Stratagene) digested with EcoRV (Toyobo, Tokyo) and transformed into DH5 strain (Toyobo). DNA sequencing was done with an ABI 310A genetic analyzer with BigDye Terminator (Applied Biosystems).
Total RNA was extracted with Trizol at 24, 48, 72, and 96 h culturing time. Each total RNA (20 mg) was electrophoresed and blotted on a Hybond-N plus filter (Amersham Biosciences). An UTP-Digoxigenin (DIG)-labeled cRNA probe was prepared from the above plasmid with T7 RNA polymerase (Promega, Madison, WI) according to the manufacturer's instructions. Filters were hybridized with the cRNA probe at 68 C overnight, washed with 2 Â SSC plus 0.1% SDS at room temperature then washed with 0:2 Â SSC plus 0.1% SDS at 65 C for 1 h. Immuno-detection was carried out with alkaline phosphatase labeled anti-DIG-antibody (Roche), CSPD (Roche), and MR-X ray films (Eastman Kodak, Rochester, NY).
Isolation of cDNA encoding ERs. A ZAP-cDNA library was constructed with 5 mg ploy-A þ RNA from cells at 48 h culturing time according to the manufacturer's instructions (Stratagene). One million plaques were screened with the above cRNA probe. Ten positive plaques were isolated under a high stringent wash condition as described above. All ten plaques were identical. This clone (er3) encoded a similar amino acid sequence to that of ER-III. Screening library with the DIG-cRNA probe prepared from the full-length clone was performed under a low stringent condition. For low stringent hybridization, hybridization was carried out at 60 C overnight and washed with 2 Â SSC plus 0.1% SDS at room temperature, and then 2 Â SSC plus 0.1% SDS at 60 C for 1 h. This screening led to isolation of two different cDNAs (er1 and er2).
Functional expression of ERs in E. coli, P. pastoris, and S. cerevisiae. The coding region for the er1, er2, and er3 cDNA was amplified with each primer including the BamHI (sense) and XhoI (antisense) recognition site, and then ligated into pRSETA (Invitrogen) plasmids after restriction enzyme digestion. The pRSETA plasmids carrying er cDNAs were transformed into BL21 (DE3) pLysS (Novagen, Madison, WI). After IPTG induction at 25 C, recombinant ERs were recovered from cells by sonication and centrifugation (26;400 g Â 15 min, 4 C). Recombinant ER1, ER2, and ER3 were purified with a nickel-chelated agarose (Qiagen, Hilden, Germany) from supernatants. Extra-tags were removed from recombinant ERs with enterokinase treatment under the manufacturer's instructions (Invitrogen). The er3 cDNA amplified with the BamHI/XhoI site was ligated into pGAPZA or pYES2/NT C (Invitrogen). The er3 cDNA amplified with the EcoRI site was ligated into pHILD2 (Invitrogen). pGAPZA and pHILD2 plasmids carrying er3 cDNA were transformed into Pichia pastoris GS115. A pYES2/NT C plasmid carrying er3 cDNA was transformed into S. cerevisiae INVSc1 (Invitrogen). Recombinant ER3 was expressed in each yeast strain according to the manufacturer's instructions.
Measurement of protein concentration and reductase activity. Protein quantity was measured with a Protein assay kit (Biorad, Hercules, CA) with bovine serum albumin (Sigma) as a standard. Erythrose reductase activity for reduction was measured with 12 mM erythrose and 0.2 mM NADPH in 50 mM phosphate buffer (pH 6.5) at 37 C. For the oxidative reaction, 100 mM erythritol and 20 mM NADP þ in 50 mM phosphate buffer (pH 9.5) at 37 C was used. Total activity was calculated from an initial rate for NADPH consumption or production using 6:3 Â 10 3 mM À1 cm À1 as the absorbance co-efficiency at 340 nm.
Polyacrylamide gel electrophoresis (PAGE) and immuno-blot analysis. SDS-PAGE was carried out with 8-25% gradient gels (Atto) and transferred to Immobilon-P PVDF membranes (Millipore, Billerica, MA) as previously described.
2) Native-and IEF-PAGE was done on the Phastsytem with PhastGels (gradient 8-25%, Amersham Biosciences). Antibodies against native ER-III were raised in mice (MBL, Nagoya). Mouse serum was purified with ammonium sulfate precipitation and used at 1:2,000 dilution for immuno-blot analysis. Immuno-reactivity of ERs on PVDF membranes was visualized on MR-X-ray films with a Renaissance western blot kit (Dupont, Wilmington, DE) after primary antibody and HRP labeled anti-mouse-IgG (Amersham Biosciences) treatment.
Results

ER-III and ER-I have aldo-keto reductase consensus sequences
ER-III and ER-I purified from T. megachiliensis were subjected to peptide sequence analysis. The N-terminal ends of ER-III and ER-I were blocked. Seventeen peptide fragments (ER-III, K1 to K17) and 3 fragments (ER-I, 1K1 to 1K3) obtained by lysyl endopeptidase digestion were separated by reverse-phase HPLC ( Fig. 1A and B) . Figures 1C, D , and E show chromatograms for peptide fragments of ER-III digested by chymotrypsin (10 fragments, Ch1-Ch10), by trypsin after citraconylation (16 fragments, T1-T16), and by Glu-C endopeptidase (6 fragments, E1-E6), respectively. The peaks of K1, K2, K4, K6, and Ch4 from ER-III were separated into 2 fragments by isocratic acetonitrile elution (K1, K1-1 and K1-2; K2, K2-1 and K2-1; K4, K4-1 and K4-2; K6, K6-1 and K6-2; Ch4, Ch4-1 and Ch4-2). The amino acid sequences of these fragments were analyzed. K7 and 1K3 fragments contained the conserved sequence (VNQIEAH) among the aldo-keto reductase family. The K16 fragment from ER-III contained a unique peptide sequence (QELFDQG) among aldo-keto reductases. These two peptide sequences were used to design degenerate oligo-nucleotide primers.
Isolation of cDNA for ER1, ER2, and ER3 Reverse transcription-polymerase chain reaction (RT-PCR) using the degenerate primers yielded a single product 389 bp long. This PCR product was sub-cloned into a blunt end vector, and the nucleotide sequence was determined. The deduced amino acid sequence contained a sequence of 22 fragments (K6-1, K6-2, K17, K8, K9, K4, K1-2, Ch4-1, Ch8, Ch7, Ch9, Ch2, Ch11, T16, T9, T12, T10, T3, T14, E2, E6, E5) and had different amino acids from 1K3 (SVGVSNFSTRLVD-LV EEASGERPAVNQIEAHPLLQQDEL). This result indicates that the PCR product was derived from the corresponding cDNA for the ER-III.
Using the RNA probe prepared from the plasmid carrying the 389 bp fragment, we performed northern blot to analyze the maximal RNA level under the 40% glucose culture condition. ER mRNA reached the maximal level at 48 h (data not shown). A cDNA library 
2)
Comparison of deduced amino acid sequences of ER1, ER2, and ER3 with aldo-keto reductases
The amino acid sequences of ER1, ER2, and ER3 were significantly homologous to that of ER-III. Figure 2 shows the diagram for the peptide fragment sequences aligned to the amino acid sequences for ER1, ER2, and ER3. The 323 amino-acid sequences from the peptide mapping of ER-III overlapped with the aminoacid sequence deduced from the er3 cDNA. Lys (ambiguous) residues, which are marked with boxes in Fig. 2 . The amino acid sequences of ER1, ER2, and ER3 were compared with other protein sequences in the NCBI database using the BLASTP program. The level of identity with aldehyde reductase ARI from S. salmonicolor 4) and aldehyde reductase from human 5) were 54% and 44%, respectively. We next compared the amino acid sequence of ERs with the amino acid sequences of other aldo-keto reductases by using the CLUSTALW programs. ERs exhibited significant levels of identity with S. cerevisiae GCY1 (36 to 38%), 6) YPR1 (35 to 38%), 7) arabinose reductase (37%), 8) M. grisea aldose reductase (AY033888)(35 to 36%), and P. gulluiermonni xylose reductase (35 to 36%). 9) As shown in Fig. 3, ER1 , ER2, and ER3 can statistically be considered as a new member of the yeast aldo-keto reductase subfamily (AKR3B) defined by Hyndman et al.
10)
Functional expression of ER1, ER2, and ER3 in E. coli
To analyze erythrose reductase activity, recombinant ER1, ER2, and ER3 were expressed in E. coli and subsequently purified with nickel-chelated agarose. The purified enzymes produced single bands with other minor bands on SDS-PAGE gels (Fig. 4A) , and immuno-blot analysis showed that the purified recombinant ER1, ER2, and ER3 were recognized by the antibody against native ER-III (Fig. 4B) . The ERs produced single bands with other minor bands on native-PAGE gels (Fig. 4C) and IEF-PAGE gels (Fig. 4D) . The relative mobilities of ER1, ER2, and ER3 on native PAGE were same as those of native ER-I, ER-II, and ER-III, 2) while the mobilities of ER1, ER2, and ER3 on IEF-PAGE were different from those of ER-I, ER-II, and ER-III. The specific activities for recombinant ER1, ER2, and ER3 with NADPH (0.2 mM) and D-erythrose (12 mM) were 104.2, 454.5, and 11.5 units/mg respectively. Recombinant ER1, ER2, and ER3 did not reduce D-erythrose with NADH as a reductant.
Native ER-III was reported to have substrate specificity towards C3-and C4-aldehydes.
2) We analyzed substrate specificity of recombinant ERs. Table 1 shows the relative activities to typical aldehydes for recombinant ERs. The substrate specificity of ERs was similar to that of native ER-III. Recombinant ER1 and ER2 showed lower NADPH consumption rates with p-nitrobenzaldehyde than recombinant ER3 and native ER-III. The K m values for the recombinant ER1, ER2, and ER3 against D-erythrose were 3.1, 8.6, and 2.2 mM. These obtained values were comparable to those of native ERs.
2)
ER3 expression in P. pastoris and S. cerevisiae P. pastoris and S. cerevisiae do not produce erythritol from glucose. To analyze whether expression of ERs in these yeasts leads to production of erythritol, we expressed er3 cDNA in P. pastoris and S. cerevisiae. Figures 5A and B show SDS-PAGE and immuno-blot analysis of recombinant ER3 expressed with pHILD2 in P. pastoris. Figures 5C and D show SDS-PAGE of recombinant ER3 expressed with pGAPZA in P. pastoris and with PYES2/NT C in S. cerevisiae. Each purified ER3 possessed specific activity as follows: 2.24 units/mg (pHILD2), 0.54 units/mg (pGAPZA), and 19.3 units/mg (pYES2/NT C). We were, however, not able to detect erythritol in the culture medium from ER3-expressing strains.
Discussion
Do er cDNAs encode corresponding native ERs?
We compared recombinant ERs with native ERs as to the amino-acid sequence and enzymatic properties. The 323 amino-acid sequences from the peptide mapping overlapped with the 330 amino-acid sequence deduced from er3 cDNA ( Fig. 1 and Fig. 2) . In all these residues, 98% of the deduced amino-acid sequence was identical with those of the peptide mapping ( Fig. 1 and Fig. 2) . The inconsistent residues might be due to low yields of Ser, Cys, Thr, and Trp on the peptide sequencer or to inseparable contaminants. The K m value against Derythrose for recombinant ER3 (2.2 mM) was comparable to that for native ER-III (8.6 mM).
2) Despite inconsistent residues or K m values, er3 likely encodes native ER-III.
In the coding region, er1 shared high homology (95.4%) with er2 (data not shown), but er1 shared 69% identity with er2 in the 5 0 un-translated region (Ookura et al., unpublished data). This suggests that er1 is K, Ch, T, and E represent peptide fragments digested with lysyl endopeptidase, chymotrypsin, trypsin and Glu-C endopeptidase respectively. Each number describes the ordered elution peak as designated in Fig. 1 . Solid triangles and circles indicate the putative active-site residues and NADPH-binding residues respectively. The amino acid sequences for oligo-nucleotide primers are marked with dashed boxes. The boxes indicate inconsistent amino acid residues between ER-III and ER3. The different residues between ER1 and ER2 are marked with solid rectangles. The consistent and homologous amino acids are marked by * and :, respectively. different from er2. Isolation of genomic clones would however be required to analyze whether er1 and er2 are derived from a same gene.
ER1 and ER2 were identical except for the 139 th (Val $ Ile) and 318 th (Asp $ Tyr) (Fig. 2, solid  squares) . From peptide mapping analysis of ER-I by lysyl-endopeptidase digestion, ER1 and ER2 had the same peptide sequences as ER-I (1K1, FEQITLSDE-EFQRVTNLI; 1K2, NIPLNDGNSIPALGYGTWQAE-PGQVGEG; 1K3, VGVSNFSTRLVDLVEEASGERP-AVNQIEAHPLLQQDEL in Fig. 1 ). These results suggest that ER-I is encoded by er1 or er2. We were unable to obtain peptide fragments that contained the 139 th nor 318 th residues. We cannot exclude the possibility that other cDNAs might encode native ER-I or ER-II.
ER1 showed different mobility from ER2 on native- Fig. 3 . Phylogenetic Tree of ER1, ER2, ER3, and Related Aldo-Keto Reductases. Amino acid sequences were analyzed using the CLUSTAL W program, 12) and the phylogenetic tree was constructed by the neighbor-joining method. 13) Amino acid sequences of the aldo-keto reductase superfamily were taken from databases. Abbreviations: HSADR, human aldose reductase (AAA51714); HSALR, human aldehyde reductase (1403439A); SSARI, S. salmonicolor aldehyde reductase I (P27800); PGXR, Pichia guilliermondii xylose reductase (AAD09330); CSXR, Candida tenuis xylose reductase (AAC25601); SCGCY, S. cerevisiae GCY1 (NP 014763); SCAR, S. cerevisiae arabinose dehydrogenase (NP 009707); SCYPR1, S. cerevisiae YPR1 (NP 010656); BTPGFS, bovine prostaglandin F synthetase I (P05980); MDSDH, apple sorbitol dehydrogenase (P28475); CTKGR, Corynebacterium 2,5-diketo-D-gluconic acid reductase (P15339).
and IEF-PAGE (Fig. 4C and D) . Recombinant ER2 showed the highest activity among ERs, while the K m values for ER1 (2.1 mM) was much lower than that for ER2 (8.6 mM). These facts suggest that the 139 th and/or 318 th residues significantly contributed to the net charge and to the enzyme activity of the ER1 and ER2. Alternatively, the difference in the residues might affect the minor conformational change around the C4-aldehyde binding site.
Purified recombinant ERs lack N-terminal Met and possess extra Asp-Arg-Trp-Gly residues after enterokinase digestion. Native ER-I and ER-III possess blocked N-terminal residues. These different amino acid residues between recombinant and native ERs might contribute to the mobility difference on IEF-PAGE. Considering the inconsistent data between native and recombinant ERs, we can not exclude the possibility that other aldo-keto reductase cDNAs encode ER-I and ER-II rather than er1 or er2.
ER1, ER2, and ER3 are classified as yeast aldo-keto reductases
Three-dimensional structural analysis of human aldose reductase indicated that the corresponding Tyr-51 acts as an acid base catalyst and that Asp-46, Lys-80, and His-113 play pivotal roles in facilitating hybrid transfer.
11) All these amino acid residues are conserved throughout the aldo-keto reductase superfamily, including ERs.
Native ERs are classified in the yeast aldo-keto reductase family (Fig. 3) . Native and recombinant ERs reduce C4-and C3-aldehydes in a NADPH dependent manner. ERs, however, cannot reduce C5-or C6-aldehydes effectively (Table 1 ). In the yeast aldo-keto reductase family, ARI from S. salmonicolor utilizes C4-aldehyde (4-chloro-3-oxobutanoate). 4) These facts strongly suggest that the yeast aldo-keto reductase family might reduce such shotchain aldehydes.
The enzyme, which possessed erythrose reductase activity from C. magnoliae, has been reported to have a KXXXGF(Y/G)XG motif.
3) This motif is conserved in the xylose reductase subfamily, but is not found among ERs in T. megachiliensis. Considering ERs can reduce C-4 and C-3 aldehydes, xylose reductase might have the capacity to reduce C-4 and C-3 aldehydes as well as C-5 aldehydes.
Erythritol biosynthesis mechanism Expression of ER3 in P. pastoris and S. cerevisiae did not lead to erythritol production in the culture media. First, judging from the low yield of erythrose reductase in each strain, more functional ERs are required for erythritol production. Secondly, a greater supply of cofactors (NADPH) or D-erythrose is required for appropriate erythritol production. D-erythrose is believed to be derived from erythrose-2-phophate in the pentose phosphate shunt, although the specific phosphatases of this reaction have not been identified. Expression of the phosphatase and enough amount supply of erythorse-2-phophate plus NADPH might improve erythritol production in each strain.
Add in Proof
The ER1/ER2 is designated AKR3B2 and ER3 designated AKR3B3 in the AKR nomenclature system.
